In another example of guideline overreach, the New England Journal of Medicine carries studies suggesting that keeping dietary salt levels too low has adverse health effects.
The latest National Business Group on Health survey finds that most large employers are still expecting large health cost increases next year.
A Deloitte brief examines trends and potential for eVisits–the use of online communication technology for provider/patient interactions.
Research published in the New England Journal of Medicine finds that the hospital pay-for-performance program adopted in England did not lead to sustained improvement in mortality rates.
The new health insurance exchange policies don’t offer particularly high levels of coverage, as revealed in a report funded by the Robert Wood Johnson Foundation.
Solvadi is the first of a new group of wonder drugs for Hepatitis C, but its cost is staggering. A brief by Milliman examines the impact of the drug on Part D plans.
There is so much talk about patient engagement that it is worth thinking more carefully about what that means and what it really means for costs and quality.
After the first wave of reform law mandated insurance signups, a substantial number of Americans remain uninsured. An Urban Institute brief describes the characteristics of this still-uninsured population.
A study published by the National Bureau of Economic Research finds that, at least in regard to Medicare spending, patient demands are relatively unimportant but physician beliefs about treatment account for a large percent of variation.
The small group insurance market covers about 19 million Americans. A Mark Farrah Associates report describes the current state of the market.